Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
about
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson's disease: an influence of chronic pramipexole in rats.Dopaminergic lesions of the dorsolateral striatum in rats increase delay discounting in an impulsive choice taskDecreasing Striatopallidal Pathway Function Enhances Motivation by Energizing the Initiation of Goal-Directed Action.Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's diseaseTrait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?Implication of dorsostriatal D3 receptors in motivational processes: a potential target for neuropsychiatric symptoms in Parkinson's disease.Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.D-512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats.Emotional manifestations of PD: Neurobiological basis.New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.Subthalamic deep brain stimulation differently alters striatal dopaminergic receptor levels in rats.Cortico-basal ganglia circuits involved in different motivation disorders in non-human primates.
P2860
Q26767268-C5A02BD2-BBBD-4792-903A-802CD41BA6E5Q30248922-8CA658B2-8676-4E33-A49C-CA406E6179BDQ35147682-1D8E6171-0774-45E9-9F78-ECEA627809F0Q35557745-559CA0A1-10CD-44AF-8DAB-A27747CF9BF0Q36037385-C6105870-6962-4B4E-B60D-C3AECBB749C1Q36709824-6C0819A9-2028-459F-B949-2A978F99F56DQ36946063-359D5906-0A50-4A15-9D4E-95BB8317B4DDQ37612626-483D1A36-A8B5-4F68-B1BB-68DA19B72584Q38419501-3F2FD3D2-667D-48B7-8234-14371C9F92C6Q38699002-5C6471BC-6F91-413B-96FF-7654F28B20F8Q38797335-343959E0-BE40-46D8-8789-50B18E78C84BQ39323947-920E8145-3DD3-41A5-BC41-D1B5A9C8FF7DQ41582688-F541930B-4066-47CC-9433-44147456D2BBQ47720163-71A21541-7C28-4E5C-BA19-210D5C0D472C
P2860
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
@en
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
@nl
type
label
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
@en
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
@nl
prefLabel
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
@en
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
@nl
P2093
P2860
P356
P1433
P1476
Pramipexole reverses Parkinson's disease-related motivational deficits in rats.
@en
P2093
Carole Carcenac
Guillaume Drui
Marc Savasta
Mathieu Favier
Sebastien Carnicella
Theo Duran
P2860
P304
P356
10.1002/MDS.25837
P407
P577
2014-02-11T00:00:00Z